
About Us
We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology – enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation – enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn
About the Role
Reporting to the Sr. Vice President, Clinical Development Operations, the Sr. Director, Clinical Vendor Procurement and Management will lead Dianthus’ clinical outsourcing, vendor procurement, and vendor governance strategy across clinical development programs to drive organizational initiatives that improve business performance, operational efficiency, and execution excellence. This remote role will serve as a strategic business partner to Clinical Development Operations and other cross-functional stakeholders, ensuring vendor identification, selection, contracting, performance oversight, and spend management are executed efficiently, compliantly, and in alignment with program goals. The ideal candidate brings deep experience in clinical outsourcing, strong business acumen, and the ability to build high-value partnerships that support successful trial delivery
We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely.
Key Responsibilities
Experience

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.